Saw palmetto for benign prostatic hyperplasia Kevin T. McVary Clinical Trials Report Pages: 251 - 251
Acute urinary retention: Who is at risk and how best to manage it? Anand PatelChristopher Chapple OriginalPaper Pages: 252 - 259
Saw palmetto and lower urinary tract symptoms: What is the latest evidence? Andrew L. AvinsStephen Bent OriginalPaper Pages: 260 - 265
Botulinum a toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms Catherine A. ThomasYao-Chi ChuangMichael B. Chancellor OriginalPaper Pages: 266 - 271
The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the united states David A. TaubJohn T. Wei OriginalPaper Pages: 272 - 281
The economics of medical therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia J. Curtis Nickel OriginalPaper Pages: 282 - 287
Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia Sanjay KasturiShane RussellKevin T. McVary OriginalPaper Pages: 288 - 292
Use of 5α-reductase inhibitors to prevent benign prostatic hyperplasia disease Leonard S. Marks OriginalPaper Pages: 293 - 303
Sexual dysfunction in the patient with prostatitis Alexander MüllerJohn P. Mulhall OriginalPaper Pages: 307 - 312
The management of chronic prostatitis in men with HIV Vincent M. SantilloFranklin C. Lowe OriginalPaper Pages: 313 - 319
How to diagnose and treat fungal infections in chronic prostatitis Gilbert J. WiseAlex Shteynshlyuger OriginalPaper Pages: 320 - 328
Chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: Are they related? Michel A. Pontari OriginalPaper Pages: 329 - 334
Is there a role for urodynamics in chronic nonbacterial prostatitis? Ricardo R. GonzalezAlexis E. Te OriginalPaper Pages: 335 - 338